Pharmaceutical intermediates are essential chemical compounds that serve as the foundational building blocks in the intricate process of drug synthesis. They are indispensable for the creation of active pharmaceutical ingredients (APIs), which are the core therapeutic components of any medication. Without high-quality intermediates, the integrity and efficacy of the final drug product cannot be guaranteed, making their production a critical step in modern pharmacology.
Among these critical compounds, N-(4-Cyanophenyl)guanidine hydrochloride stands out as a significant pharmaceutical intermediate. Known by its CAS number 373690-68-7, this compound plays a pivotal role in the production of specialized APIs. Its molecular formula, C8H9ClN4, and molecular weight of 196.637 indicate a precise chemical structure engineered for specific reactions, ensuring its suitability for complex synthetic pathways.
This high-grade intermediate is characterized by its appearance as a white crystalline powder. Our rigorous quality control ensures an assay of greater than or equal to 98.0%, meeting stringent purity standards essential for pharmaceutical applications. It is typically supplied in 25 kg drums, with flexible packaging options available to accommodate specific customer requirements. The primary application of N-(4-Cyanophenyl)guanidine hydrochloride is as a key intermediate for Etravirine (CAS: 269055-15-4), an important antiviral medication. Its consistent quality directly contributes to the synthesis of a safe and effective therapeutic agent, crucial for treating various viral infections.
Pharmaceutical intermediates are vital for several reasons. They allow for the sequential and controlled chemical transformations necessary to build complex API molecules from simpler starting materials. This multi-step synthesis approach is crucial for achieving the exact molecular structure required for therapeutic activity, while also enabling multiple checkpoints for quality control throughout the production chain. Furthermore, leveraging high-quality intermediates significantly enhances manufacturing efficiency and scalability. By breaking down complex synthesis into manageable steps, production becomes more streamlined, allowing for higher yields and reduced waste. This also means that potential issues can be identified and corrected early, preventing costly delays in the overall drug development timeline.
It is important to distinguish pharmaceutical intermediates from Active Pharmaceutical Ingredients (APIs). While APIs are the final, active substances with direct therapeutic effects on the human body, intermediates are precursors that undergo further molecular modification and purification to become APIs. Although intermediates may not possess direct therapeutic properties and typically face less stringent direct patient-use regulations than APIs, their quality is paramount. Impurities or inconsistencies in an intermediate can severely compromise the purity, potency, and safety of the final API. Therefore, manufacturers of pharmaceutical intermediates must adhere to rigorous quality management systems and conduct comprehensive testing, including advanced analytical techniques such as chromatography and spectroscopy, to ensure every batch meets the highest standards.
As a dedicated pharmaceutical intermediate manufacturer, we understand the critical role our products play in global healthcare. We are committed to providing pharmaceutical companies worldwide with high-purity N-(4-Cyanophenyl)guanidine hydrochloride. Whether you are looking to buy N-(4-Cyanophenyl)guanidine hydrochloride for research and development or seeking a reliable supplier for bulk production, our focus on quality and consistency remains unwavering. We aim to offer competitive price options while maintaining superior product integrity. For those seeking to purchase N-(4-Cyanophenyl)guanidine hydrochloride, our expertise ensures a seamless procurement process and a product that adheres to the highest industry standards. Our global network enables efficient distribution, making us a trusted partner for your pharmaceutical material needs, contributing to the broader market for pharmaceutical intermediates.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.